Back to ALDXView Full LandscapeView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
2 competitors in Dry Eye Syndrome
AUPH0.05% Voclosporin Ophthalmic Solution (VOS)
Phase 3HRTIS.HEcis-UCA ophthalmic solution 1.0%
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
ADX-2191 (intravitreal methotrexate 0.8%)Phase 3
Proliferative Vitreoretinopathy
Reproxalap Ophthalmic Solution (0.25%) QIDPhase 3
Dry Eye
Reproxalap Ophthalmic Solution (0.5%)Phase 3
Allergic Conjunctivitis
ADX-102 1% Topical Dermal Cream (reproxalap)Phase 3
Sjogren-Larsson Syndrome
Reproxalap Ophthalmic Solution (0.25% Novel Formulation) QID to BIDPhase 3
Dry Eye
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts